tradingkey.logo

BRIEF-Rallybio Announces Initiation Of Dosing In RLYB212 Phase 2 Clinical Trial

ReutersFeb 11, 2025 1:19 PM

- Rallybio RLYB.O:

  • RALLYBIO ANNOUNCES INITIATION OF DOSING IN RLYB212 PHASE 2 CLINICAL TRIAL

  • RALLYBIO CORP - PK AND SAFETY DATA EXPECTED IN 2Q AND 3Q 2025

Source text: ID:nBw34KkMla

Further company coverage: RLYB.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI